Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 7,500 shares at $28.52 ($211K) on 2015-01-27, disclosed to the SEC on 2015-01-28.
Scheduled sale ($211k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.03 | 5,200 | $146K | 69.0% |
| 2 | $28.52 | 2,300 | $66K | 31.0% |
| Total | $28.18 avg | 7,500 | $211K | 100% |
| Filing → |
| ATHA | SELL | 2025-07-02 | $7K | — | Filing → |
| ATHA | SELL | 2025-01-03 | $14K | — | Filing → |
| ATHA | SELL | 2024-09-05 | $3K | — | Filing → |